Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-1

 

Virax Biolabs Group Limited

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

 

 

 

 

 

 

 

 

 

 

 

Security

Security

Fee

Amount

Proposed

Maximum

Fee

Amount of

 

Type

Class

Calculation

Registered(1)

Maximum

Aggregate

Rate

Registration

 

 

Title

or Carry

 

Offering

Offering

 

Fee

 

 

 

Forward Rule

 

Price Per

Price(1)

 

 

 

 

 

 

 

Unit(2)

 

 

 

 

Newly Registered Securities

 

Fees to be

Equity

Ordinary

Rule 457(c)

11,453,062

$.705

$8,074,408.71

0.0001102

$889.80

 

Paid

shares, par value

 

 

US$0.0001 per

 

 

 

share(3)

 

 

 

Total Offering Amounts

 

$8,074,408.71

0.0001102

$889.80

 

 

Total Fees Previously Paid

 

 

 

 

 

 

Total Fee Offsets

 

 

 

 

 

 

Net Fee Due

 

 

 

$889.80

 

 

1.
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the ordinary shares being registered hereunder include such indeterminate number of ordinary shares as may be issuable with respect to such ordinary shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
2.
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) promulgated under the Securities Act, based upon the average of the high ($0.75) and low ($0.66) prices of the ordinary shares as reported on the Nasdaq Capital Market on March 17, 2023.
3.
Comprised of (i) 1,500,000 PIPE Shares (as defined in the Registration Statement), (ii) 2,343,309 Pre-Funded Warrant Shares (as defined in the Registration Statement), (iii) 3,497,412 Series A Options Shares (as defined in the Registration Statement), (iv) 3,843,309 Series B Option Shares (as defined in the Registration Statement); and (iv) 269,032 Placement Warrant Shares (as defined in the Registration Statement).